← Back to Clinical Trials
Recruiting NCT05676970

NCT05676970 Using a Telehealth and Shared Decision-Making Model to Address Preventative Medicine Strategies Among Communities in Louisiana

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05676970
Status Recruiting
Phase
Sponsor Xavier University of Louisiana.
Condition Preventative Medicine
Study Type INTERVENTIONAL
Enrollment 360 participants
Start Date 2024-01-01
Primary Completion 2028-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Telehealth: Personalized Preventative Medicine StrategiesTeleHealth: Preventative Medicine Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 360 participants in total. It began in 2024-01-01 with a primary completion date of 2028-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a 12-18 month behavioral intervention study to assess the impact of enrolling individuals a clinical pharmacist run Telehealth education focused on wellness and preventive health strategies. Individuals will be randomized to either a wellness education only model focusing on nutrition, diabetes, hyperlipidemia and hypertension or a wellness education model with personalized preventative medicine strategies for the patient. All participants will complete individual and group based interventions. Individuals will be recruited from target work industries such as health workers, teachers aides and the food industry. We are recruiting individuals who come from urban, semi-rural or rural communities or have additional social determinants of health that indicate social vulnerability. The primary outcome is willingness to participate in preventative medicine strategies to prevent development of chronic medical conditions. The secondary outcome is barriers to preventive medicine strategies including for chronic preventable disease such as nutrition, hypertension, hyperlipidemia, diabetes and medication compliance.

Eligibility Criteria

Inclusion Criteria: 1. Adults aged 18 years to 55 years of age 2. Able to speak English 3. Currently employed or seeking training in target industries such as: healthcare, education, beauty, hospitality, food (culinary) and industrial plant workers. 4. Able to use Telehealth technology via tablet, cell phone, or computer Exclusion Criteria: 1\. Individuals who are unable to give informed consent.

Contact & Investigator

Central Contact

Sara Al-Dahir, PharmD, PhD

✉ saaldah@xula.edu

📞 5045205766

Principal Investigator

Sara Al-Dahir, PhD

PRINCIPAL INVESTIGATOR

Xavier University of Louisiana.

Frequently Asked Questions

Who can join the NCT05676970 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Preventative Medicine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05676970 currently recruiting?

Yes, NCT05676970 is actively recruiting participants. Contact the research team at saaldah@xula.edu for enrollment information.

Where is the NCT05676970 trial being conducted?

This trial is being conducted at New Orleans, United States.

Who is sponsoring the NCT05676970 clinical trial?

NCT05676970 is sponsored by Xavier University of Louisiana.. The principal investigator is Sara Al-Dahir, PhD at Xavier University of Louisiana.. The trial plans to enroll 360 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology